For this reason, Ku70 might be considered as a promising therapeutic target to induce the selective apoptosis of breast cancer cells overexpressing TrkA, although further in vitro and in vivo studies are required to confirm this hypothesis. The gene discussed is NTRK1; the disease is breast carcinoma.